Professor
The University of Texas MD Anderson Cancer Center
Houston, Texas
Dr. Mimi Hu is a Professor and Deputy Chair of Clinical Affairs in the Department of Endocrine Neoplasia and Hormonal Disorders at The University of Texas MD Anderson Cancer Center in Houston, TX. She graduated from Rice University with a degree in mechanical engineering and obtained her medical degree from the University of Texas - Houston Health Sciences Center. After completing her residency and endocrine fellowship at Baylor College of Medicine, where she also served as chief medical resident, she joined the faculty at MD Anderson in 2007. She is the Program Director for the Oncologic Endocrine Fellowship program for advanced training in endocrine cancer evaluation and management and the endocrine care for the cancer population. Dr. Hu's clinical expertise is in the evaluation and treatment of patients with thyroid carcinoma (differentiated and medullary), hereditary endocrine neoplasia disorders and metabolic bone and mineral disorders. She is the primary investigator and collaborator on multiple clinical trials evaluating various targeted therapies for advanced thyroid carcinoma. She was the lead investigator in the multi-center, clinical study investigating denosumab in the management of hypercalcemia of malignancy refractory to intravenous bisphosphonates, which led to this as an added FDA-indication for denosumab in 2014. She has published articles and book chapters evaluating the management of medullary thyroid carcinoma, multiple endocrine neoplasia, bone health in cancer patients, and paraneoplastic endocrine disorders.
Disclosure information not submitted.
Friday, November 17, 2023
4:00 PM – 4:45 PM EST